Can You Trust Your Doctor?
The relationship between pharmaceutical companies and physicians is one of the most studied — and most contested — topics in healthcare research. On one hand, doctors are highly trained professionals bound by ethical obligations. On the other, the industry spends billions every year cultivating relationships with prescribers. What does the evidence actually say?
What is CMS Open Payments?
The Physician Payments Sunshine Act, passed as part of the Affordable Care Act in 2010, requires drug and medical-device companies to report all payments, gifts, and transfers of value to physicians and teaching hospitals. The CMS (Centers for Medicare and Medicaid Services) publishes this data annually at openpaymentsdata.cms.gov.
Payments range from a free lunch at a conference ($30) to multi-million-dollar research contracts. Common categories include food and beverage, speaking fees, consulting fees, education, and research payments.
What does the research show?
Multiple peer-reviewed studies have found associations between industry payments and prescribing behavior:
- A 2016 JAMA Internal Medicine study found that physicians who received even a single free industry meal were significantly more likely to prescribe the promoted brand-name drug over cheaper alternatives.
- A 2019 study in PLOS Medicine found that higher payment totals were associated with higher brand-name prescribing rates across multiple drug classes.
- Industry-funded research is more likely to reach industry-favorable conclusions, even when controlling for study quality.
It is important to emphasize that correlation is not causation. Physicians who receive payments may also be specialists in areas where brand-name drugs are genuinely more appropriate. Research payments often fund legitimate clinical trials.
What questions should you ask?
- Does a generic or biosimilar equivalent exist for any prescription I receive?
- Do you have any financial relationships with the company that makes this drug or device?
- Are there non-pharmaceutical alternatives I should consider first?
- Can you explain why this particular brand is preferred over alternatives?
Most physicians are honest and will welcome these questions. The goal is not suspicion but informed shared decision-making — the foundation of good medicine.
Search your provider's payment record →